IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $969,251 | +42.2% | 23,623 | +23.9% | 0.04% | +23.3% |
| Q1 2023 | $681,455 | -3.0% | 19,067 | +2.5% | 0.03% | -11.8% |
| Q4 2022 | $702,598 | -37.0% | 18,602 | -26.2% | 0.03% | -45.2% |
| Q3 2022 | $1,115,000 | +27.6% | 25,199 | +6.8% | 0.06% | +24.0% |
| Q2 2022 | $874,000 | +23.1% | 23,595 | +23.1% | 0.05% | +25.0% |
| Q1 2022 | $710,000 | +25.7% | 19,161 | +3.1% | 0.04% | +25.0% |
| Q4 2021 | $565,000 | -15.9% | 18,578 | -7.3% | 0.03% | -30.4% |
| Q3 2021 | $672,000 | -15.3% | 20,033 | +0.7% | 0.05% | -17.9% |
| Q2 2021 | $793,000 | -33.5% | 19,887 | -25.0% | 0.06% | -47.2% |
| Q1 2021 | $1,192,000 | +6.0% | 26,509 | +33.4% | 0.11% | -15.9% |
| Q4 2020 | $1,124,000 | +15.4% | 19,875 | -3.2% | 0.13% | -3.8% |
| Q3 2020 | $974,000 | -19.9% | 20,536 | -0.4% | 0.13% | -30.3% |
| Q2 2020 | $1,216,000 | +17.8% | 20,618 | -5.5% | 0.19% | -6.9% |
| Q1 2020 | $1,032,000 | -24.5% | 21,827 | -3.5% | 0.20% | -27.9% |
| Q4 2019 | $1,366,000 | -2.4% | 22,615 | -3.2% | 0.28% | +23.3% |
| Q3 2019 | $1,400,000 | -10.6% | 23,373 | -4.1% | 0.23% | -15.3% |
| Q2 2019 | $1,566,000 | -20.0% | 24,373 | +1.1% | 0.27% | -23.2% |
| Q1 2019 | $1,957,000 | – | 24,107 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |